Annabidiol Corp.
ACBD · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $59 | $104 | $79 | $41 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $59 | $104 | $79 | $41 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.003 | -0 | -0 |
| % Growth | 89.7% | -2,800% | 50% | – |
| Operating Cash Flow | – | – | – | -$0 |
| Capital Expenditures | – | – | – | $0 |
| Free Cash Flow | – | – | – | -$0 |